Short answer · Medically reviewed summary · Last updated: 2026-04-07
Doose syndrome, clinically known as Myoclonic-Atonic Epilepsy (MAE), does not have a unique, dedicated ICD-10 or ICD-9 code; instead, it is classified under broader epilepsy categories. In ICD-10, it is typically coded as G40.3 (Generalized idiopathic epilepsy and epileptic syndromes), while in ICD-9, it was categorized under 345.1 (Generalized convulsive epilepsy). What is the clinical classification of Doose syndrome? Because Doose syndrome is a complex epilepsy syndrome rather than a single structural injury, medical coding systems like ICD-10 and ICD-9 use "umbrella" codes to capture the patient's diagnostic profile.
Doose syndrome, clinically known as Myoclonic-Atonic Epilepsy (MAE), does not have a unique, dedicated ICD-10 or ICD-9 code; instead, it is classified under broader epilepsy categories. In ICD-10, it is typically coded as G40.3 (Generalized idiopathic epilepsy and epileptic syndromes), while in ICD-9, it was categorized under 345.1 (Generalized convulsive epilepsy).
Because Doose syndrome is a complex epilepsy syndrome rather than a single structural injury, medical coding systems like ICD-10 and ICD-9 use "umbrella" codes to capture the patient's diagnostic profile. Doose syndrome, or Myoclonic-Atonic Epilepsy, is characterized by multiple seizure types, most notably myoclonic-atonic seizures, where a child experiences a sudden muscle jerk followed by a loss of muscle tone (a drop). In the 65 members of the Doose syndrome community on DiseaseMaps.org, we see that these codes are often used alongside secondary codes that specify the presence of status epilepticus or developmental delays, which are common clinical features of the condition.
The diagnosis of Doose syndrome is primarily clinical and electroencephalographic (EEG). There is no single blood test or genetic marker that confirms the diagnosis, though genetic testing is increasingly utilized to rule out other metabolic or genetic epilepsy syndromes. Clinicians look for specific patterns:
While the exact genetic architecture of Doose syndrome is not fully understood, it is considered a polygenic disorder with a strong underlying genetic predisposition. Most cases are sporadic, meaning they occur in families without a prior history of epilepsy. However, researchers have identified that siblings of children with Doose syndrome have a slightly higher risk of developing epilepsy compared to the general population. Genetic counseling is highly recommended for families to discuss the nuances of recurrence risk and the polygenic nature of the condition.
Living with a diagnosis of Doose syndrome requires a multidisciplinary approach involving pediatric neurologists, epileptologists, and sometimes metabolic specialists. Because the condition is often refractory to standard anti-seizure medications, many families explore dietary therapies, such as the ketogenic diet or modified Atkins diet, which have shown efficacy in treating Doose syndrome. Beyond medical management, the emotional impact on caregivers is significant. Connecting with the 65 members of the Doose syndrome community on DiseaseMaps.org provides a vital space for sharing experiences regarding treatment resistance and the daily navigation of life with a child who has unpredictable seizures.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.